SAB Biotherapeutics Inc Capital Reinvestment Ratio
SAB Biotherapeutics Inc capital reinvestment ratio. SAB Biotherapeutics Inc (SABS) has a Capital Reinvestment Ratio of 0.54x as of December 2022, meaning it reinvests 1% of its operating cash flow ($216.72K) in capital expenditures ($117.75K). Check SABS capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of SAB Biotherapeutics Inc (2020–2021)
Capital reinvestment ratio of SAB Biotherapeutics Inc from 2020 to 2021. This chart tracks SAB Biotherapeutics Inc's Capital Reinvestment Ratio across 2 annual periods. Also explore SABS net asset momentum to track the company's year-over-year net asset growth rate.
SAB Biotherapeutics Inc Capital Reinvestment Ratio by Year (2020–2021)
SAB Biotherapeutics Inc capital reinvestment ratio by year from 2020 to 2021. For the full cash flow conversion analysis, see SAB Biotherapeutics Inc operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 5.51x | $1.99 Million | $10.94 Million | ▲ +332.8% |
| 2020 | 1.27x | $10.00 Million | $12.73 Million | — |